Abstract

AdultA-strain mice in the weight-range 15 to 20 g were irradiated to 350 or 500 r, followed by the injection, divided between the intravenous and intraperitoneal routes, of suspensions of spleen cells obtained fromCBAor (CBAxA)F1mice, donors and recipients being matched for sex. After the lapse of 18 to 25 days all mice, including control batches which had received irradiation but not spleen cells, were challenged with donor-type skin grafts. Mice irradiated to 500 r which receivedCBAspleen cells in doses from 500 to 1500 million developed severe graft-versus-host disease, fatal in most cases. Rejection of the grafts occurred in irradiated controls after periods ranging from 8 to 23 days. Mice receiving 500r followed by (CBAxA)F1spleen cells showed prolonged survival of skin grafts, amounting to 90 days or more in animals which had received the highest dose of cells (12 x 109). Analysis of the phenomenon by means of Simonsen’s discriminant spleen assay showed that approximately 85% of the immunologically competent spleen cells of the graft-bearing animals were replaced by cells of donor origin; the remainder, however, retained the power to react immunologically against third-party (C57BL) antigens. It was also possible to secure adoptive rejection of grafts by injection of 60 to 90 millionA-strain lymph node cells pre-sensitized againstCBA. It is concluded that the state of specific unresponsiveness induced in the adultAstrain mice represented a specific central inhibition of the mechanism of immunological response and could thus be equated to immunological tolerance as classically defined. Prior splenectomy not only abolished the tolerance phenomenon, but actually reversed it, there being clear signs of an immunity resulting from the irradiation and injection procedure. This result is discussed in terms of the significance of antigen dose-level for the induction of tolerance.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.